Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
XTL Biopharmaceuticals Ltd. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
XTLB
Nasdaq
2836
www.xtlbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for XTL Biopharmaceuticals Ltd.
XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million
- Aug 14th, 2024 1:15 pm
XTL Entered Definitive Agreement to Acquire The Social Proxy
- Jun 5th, 2024 1:15 pm
XTL To Aquire The Social Proxy
- Mar 20th, 2024 2:15 pm
Scroll